Xconomy Boston

Histogenics Corporation Garners $9,000,000 Series B Funding Round

  • Feed Type
  • Date
    9/4/2008
  • Company Name
    Histogenics Corporation
  • Mailing Address
    830 Winter Street, 3rd Floor Waltham, MA 02451
  • Company Description
    Histogenics Corporation’s approach to cartilage regeneration is to use a technology platform that employs advances in cell biology, tissue culture, engineering, and materials science to affect tissue repair.
  • Website
    http://www.histogenics.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $9,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Boston Millennia Partners
  • Venture Investor
    Foundation Medical Partners
  • Venture Investor
    Stryker Corporation

Add Your Thoughts

You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted.
By clicking "Publish," you are agreeing to these Terms and Conditions.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.